TEVA Related Analyst EPS View

Feb 8, 2013 07:17 AM Canaccord Genuity Downgrades Teva Pharma (TEVA) to Hold

Dec 10, 2012 09:30 AM Investor Meeting is Potential Catalyst for Teva (TEVA)

Dec 3, 2012 11:14 AM Teva Pharma (TEVA) Investors Look To Analyst Day

Oct 16, 2012 12:54 PM Canaccord Genuity Cuts Price Target on Teva (TEVA)

Aug 3, 2012 01:45 PM Oppenheimer Maintains a 'Perform' on Teva Pharma (TEVA); Wait for Clarity on Pipeline

Aug 3, 2012 10:33 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); A Little Reaction or Side Effect?

Aug 3, 2012 09:45 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink

Jul 20, 2012 08:31 AM Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo

Jun 26, 2012 11:05 AM UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock

May 25, 2012 01:21 PM Barclays Maintains an 'Equalweight' on Teva Pharma (TEVA); Adjusting Estimates After Business Update

May 25, 2012 10:52 AM UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call

May 25, 2012 09:39 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Adjusting Estimates; Copaxone Still In Focus

May 25, 2012 07:55 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); Adjusting Estimates

May 10, 2012 11:11 AM Canaccord Genuity on Specialty Pharma: TEVA's Q1 Effect on Specialty Pharma (TEVA, WPI, PRGO & MYL)

May 10, 2012 08:32 AM Needham & Company Upgrades Teva Pharma (TEVA) to Hold; Same Old Growth Drags and Risk Overhangs

May 4, 2012 11:42 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Focus Moves to Copaxone Trial

Apr 19, 2012 10:07 AM Canaccord Genuity on Specialty Pharmaceutical: Top Picks Have Less Volatility With Earnings

Apr 9, 2012 02:10 PM Barclays on U.S. Specialty Pharmaceuticals: Model Adjustments on MYL, PRX, TEVA, & WCRX

Apr 4, 2012 11:23 AM Canaccord Genuity on Life Sciences/Specialty Pharma: What an Actavis Deal Could Mean to Watson (WPI) and the Sector

Feb 16, 2012 10:04 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Thesis Continues Playing Out - Copaxone Decision Key to Next Leg Up

Feb 16, 2012 08:57 AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Momentum Carry-Over into 2012 Could Provide Upside to Current Expectations